Ortin Laboratories Book Value Per Share vs. Total Debt

ORTINLAB   19.63  0.00  0.00%   
Based on Ortin Laboratories' profitability indicators, Ortin Laboratories Limited may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Ortin Laboratories' ability to earn profits and add value for shareholders.
For Ortin Laboratories profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Ortin Laboratories to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Ortin Laboratories Limited utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Ortin Laboratories's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Ortin Laboratories Limited over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Please note, there is a significant difference between Ortin Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ortin Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ortin Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Ortin Laboratories Total Debt vs. Book Value Per Share Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Ortin Laboratories's current stock value. Our valuation model uses many indicators to compare Ortin Laboratories value to that of its competitors to determine the firm's financial worth.
Ortin Laboratories Limited is considered to be number one stock in book value per share category among its peers. It also is rated top company in total debt category among its peers making up about  5,186,475  of Total Debt per Book Value Per Share. Comparative valuation analysis is a catch-all model that can be used if you cannot value Ortin Laboratories by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Ortin Laboratories' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Ortin Total Debt vs. Book Value Per Share

Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Ortin Laboratories

Book Value per Share

 = 

Common Equity

Average Shares

 = 
3.48 X
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Ortin Laboratories

Total Debt

 = 

Bonds

+

Notes

 = 
18.02 M
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.

Ortin Total Debt vs Competition

Ortin Laboratories Limited is rated top company in total debt category among its peers. Total debt of Health Care industry is now estimated at about 41.57 Billion. Ortin Laboratories adds roughly 18.02 Million in total debt claiming only tiny portion of equities under Health Care industry.
Total debt  Capitalization  Revenue  Workforce  Valuation

Ortin Laboratories Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Ortin Laboratories, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Ortin Laboratories will eventually generate negative long term returns. The profitability progress is the general direction of Ortin Laboratories' change in net profit over the period of time. It can combine multiple indicators of Ortin Laboratories, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-53.1 M-50.4 M
Operating Income-67.7 M-64.3 M
Income Before Tax-70.8 M-67.2 M
Total Other Income Expense Net-3.1 M-3.3 M
Net Loss-80.4 M-76.4 M
Income Tax Expense9.7 M10.1 M
Net Interest Income-4.6 M-4.8 M
Interest Income176.4 K167.6 K
Net Loss-602.1 K-572 K
Net Loss-842.4 K-800.3 K
Change To Netincome3.3 M3.2 M

Ortin Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Ortin Laboratories. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Ortin Laboratories position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Ortin Laboratories' important profitability drivers and their relationship over time.

Use Ortin Laboratories in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ortin Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ortin Laboratories will appreciate offsetting losses from the drop in the long position's value.

Ortin Laboratories Pair Trading

Ortin Laboratories Limited Pair Trading Analysis

The ability to find closely correlated positions to Ortin Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ortin Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ortin Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ortin Laboratories Limited to buy it.
The correlation of Ortin Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ortin Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ortin Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ortin Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Ortin Laboratories position

In addition to having Ortin Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Momentum Thematic Idea Now

Momentum
Momentum Theme
Large corporations operating in software, education, financial and car manufacturing industries. The Momentum theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Momentum Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Ortin Stock

To fully project Ortin Laboratories' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Ortin Laboratories at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Ortin Laboratories' income statement, its balance sheet, and the statement of cash flows.
Potential Ortin Laboratories investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Ortin Laboratories investors may work on each financial statement separately, they are all related. The changes in Ortin Laboratories's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ortin Laboratories's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.